• The iPhone to Skip?

  • Sep 16 2024
  • Length: 29 mins
  • Podcast

The iPhone to Skip?

Listen for free

View show details

  • Summary

  • Join Pete Najarian and Marc LoPresti on today's episode of Rebel's Edge as they discuss stocks including Apple failing to impress with the iPhone 16, Oracle ripping to the upside, and both Ascendis Pharma and Nuvalent showing promise in biotech. Gain a deeper understanding of these stocks as Pete and Marc share their perspectives, potential growth prospects, and market predictions. They also talk about Olympic ratings and whether NFL teams should play rookie QBs. Stay on the cutting edge with Rebel's Edge.
    Show more Show less
Marketing Economics
Show more Show less

What listeners say about The iPhone to Skip?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available